Citation: | Yuya Cheng, Peize Wu, Peng Xiao, Ming Li. Determination of related substances in disulfide-rich peptide ziconotide by establishing tandem mass spectrometry methods[J]. Journal of Pharmaceutical Analysis, 2024, 14(10): 101037. doi: 10.1016/j.jpha.2024.101037 |
[1] |
E. Prommer, Ziconotide: a new option for refractory pain, Drugs Today 42 (2006) 369-378.
|
[2] |
R.D. Josephs, G. Martos, M. Li, et al., Establishment of measurement traceability for peptide and protein quantification through rigorous purity assessment-a review, Metrologia 56 (2019), 044006.
|
[3] |
L.C. Wu, F. Chen, S.L. Lee, et al., Building parity between brand and generic peptide products: regulatory and scientific considerations for quality of synthetic peptides, Int. J. Pharm. 518 (2017) 320-334.
|
[4] |
P. Bros, R.D. Josephs, N. Stoppacher, et al., Impurity determination for hepcidin by liquid chromatography-high resolution and ion mobility mass spectrometry for the value assignment of candidate primary calibrators, Anal. Bioanal. Chem. 409 (2017) 2559-2567.
|
[5] |
M. Gongora-Benitez, J. Tulla-Puche, F. Albericio, Multifaceted roles of disulfide bonds. Peptides as therapeutics, Chem. Rev. 114 (2014) 901-926.
|